Myocardial kinetics of 201Thallium, 99mTc-tetrofosmin, and 99mTc-sestamibi in an acute ischemia–reperfusion model using isolated rat heart

Objective201Thallium (TL), 99mTc-tetrofosmin (TF), and 99mTc-sestamibi (MIBI) are extensively used as myocardial perfusion agents. The objective of the present study was to evaluate their kinetics under acute ischemia–reperfusion.MethodsIsolated rat hearts, perfused by the Langendorff method at a constant flow rate of 10 ml/min, were allotted to normal control, mild ischemia, and severe ischemia groups, in which 20-min tracer wash-in was conducted followed by a 25-min tracer washout. No-flow ischemia (15 min for mild ischemia groups; 30 min for severe ischemia groups) was induced before conducting wash-in and washout in the ischemia groups. Whole-heart radioactivity was determined with an external gamma detector. Myocardial flow rate (K1, ml/min) and clearance rate (k2, min−1) were calculated.ResultsK1TL, K1TF, and K1MIBI decreased according to the severity of ischemia (K1TL 5.32 ± 0.53, 4.76 ± 0.70, and 1.44 ± 0.59; K1TF 3.80 ± 0.70, 2.73 ± 0.99, and 1.09 ± 0.45; and K1MIBI 3.45 ± 1.10, 2.15 ± 0.82, and 1.05 ± 0.13, in the normal control, mild, and severe ischemia groups, respectively). K1 was significantly higher for TL than for the 99mTc tracers (P < 0.05), but the 99mTc tracers had equivalent K1 values. k2TL increased significantly (P < 0.05) in the ischemia groups (k2TL 0.062 ± 0.013, 0.11 ± 0.045, and 0.12 ± 0.035), but showed no significant difference between the ischemia groups. k2MIBI and k2TF were significantly (P < 0.05) lower than k2TL and increased significantly (P < 0.05) in the severe ischemia group (k2TF 0.0056 ± 0.0022, 0.0037 ± 0.0015, and 0.024 ± 0.015; and k2MIBI 0.00072 ± 0.0011, 0.00038 ± 0.00076, and 0.042 ± 0.034). k2MIBI was significantly (P < 0.05) lower than k2TF in the normal control and mild ischemia groups.ConclusionsTracer extraction was higher for TL than for the 99mTc tracers and all tracers decreased according to the severity of ischemia–reperfusion in the three tracer groups. The clearance kinetics of not only MIBI but also TF is possibly useful for the evaluation of the severity of ischemia, and the Langendorff method and a methodological approach by continuous determinations of radioactivity may serve for the quantitative analysis of tracer kinetic profiles.

[1]  H. Schicha,et al.  201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts. , 2002, Nuclear medicine and biology.

[2]  G. Johnson,et al.  Technetium-99m sestamibi kinetics in reperfused canine myocardium , 1995, European Journal of Nuclear Medicine.

[3]  J. Kronauge,et al.  Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. , 1990, Circulation.

[4]  R. Virmani,et al.  Platelets protect against myocardial dysfunction and injury induced by ischemia and reperfusion in isolated rat hearts. , 1993, Circulation research.

[5]  T. Sakata,et al.  Single Oral Dose of Geranylgeranylacetone Induces Heat-Shock Protein 72 and Renders Protection Against Ischemia/Reperfusion Injury in Rat Heart , 2001, Circulation.

[6]  P. Olivier,et al.  (201)Tl and (99m)Tc-MIBI retention in an isolated heart model of low-flow ischemia and stunning: evidence of negligible impact of myocyte metabolism on tracer kinetics. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Mehta,et al.  Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts. , 1997, Circulation.

[8]  Zhonglin Liu,et al.  Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[9]  G. Beller,et al.  99mTc‐Sestamibi Uptake and Retention During Myocardial Ischemia and Reperfusion , 1993, Circulation.

[10]  J. Zwischenberger,et al.  Intermittent ischemia produces a cumulative depletion of mitochondrial adenine nucleotides in the isolated perfused rat heart. , 1990, Circulation research.

[11]  S. Kaul,et al.  Thallium 201 kinetics in stunned myocardium characterized by severe postischemic systolic dysfunction. , 1990, Circulation.

[12]  V. Manninen,et al.  Thallium inhibition of ouabain-sensitive sodium transport and of the (Na+ plus K+)-ATPase in human erythrocytes. , 1975, Biochimica et biophysica acta.

[13]  J. Leppo,et al.  Myocardial extraction of technetium-99m-[2-(1-methoxybutyl) isonitrile] in the isolated rabbit heart: a myocardial perfusion agent with high extraction and stable retention. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  T. Araki,et al.  Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  R. Reneman,et al.  Lipid Alterations in Isolated, Working Rat Hearts During Ischemia and Reperfusion: Its Relation to Myocardial Damage , 1989, Circulation research.

[16]  T. Akera,et al.  O2 free radicals: cause of ischemia-reperfusion injury to cardiac Na+-K+-ATPase. , 1987, The American journal of physiology.

[17]  N. Ohte,et al.  Reverse redistribution phenomenon on rest (99m)Tc-tetrofosmin myocardial single photon emission computed tomography involves impaired left ventricular contraction in patients with acute myocardial infarction. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[18]  P. McLaughlin,et al.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? , 1990, Circulation.

[19]  B. Pitt,et al.  Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. , 1975, Circulation.

[20]  B. Holman,et al.  Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  A comparison of Tl-201, Tc-99m sestamibi, and Tc-99m tetrofosmin myocardial perfusion scintigraphy in patients with mild to moderate coronary stenosis , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[22]  D. Berman.  Introduction--Technetium-99m myocardial perfusion imaging agents and their relation to thallium-201. , 1990, The American journal of cardiology.